43
Participants
Start Date
November 7, 2016
Primary Completion Date
May 25, 2019
Study Completion Date
May 25, 2019
TAP block ropivacaine
TAP block placebo
General anesthesia
Induction PROPOFOL 10mg/ml REMIFENTANIL 50 μg/ml CISATRACURIUM 2mg/ml if necessary DEXAMETHASONE 8 mg KETAMINE 0,15mg/kg Maintenance PROPOFOL 10mg/ml REMIFENTANIL 50 μg/ml
CHU de Rennes, Rennes
Rennes University Hospital
OTHER